Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1986 1
1987 1
1988 1
1989 1
1990 2
1991 2
1992 1
1993 2
1994 5
1995 2
1996 8
1997 6
1998 3
1999 5
2000 9
2001 5
2002 7
2003 6
2004 8
2005 18
2006 29
2007 35
2008 43
2009 39
2010 35
2011 34
2012 38
2013 42
2014 39
2015 37
2016 45
2017 40
2018 32
2019 47
2020 44
2021 35
Text availability
Article attribute
Article type
Publication date

Search Results

621 results
Results by year
Filters applied: . Clear all
Page 1
Staging of bladder cancer.
Magers MJ, Lopez-Beltran A, Montironi R, Williamson SR, Kaimakliotis HZ, Cheng L. Magers MJ, et al. Among authors: lopez beltran a. Histopathology. 2019 Jan;74(1):112-134. doi: 10.1111/his.13734. Histopathology. 2019. PMID: 30565300 Review.
Metabolic phenotype of bladder cancer.
Massari F, Ciccarese C, Santoni M, Iacovelli R, Mazzucchelli R, Piva F, Scarpelli M, Berardi R, Tortora G, Lopez-Beltran A, Cheng L, Montironi R. Massari F, et al. Among authors: lopez beltran a. Cancer Treat Rev. 2016 Apr;45:46-57. doi: 10.1016/j.ctrv.2016.03.005. Epub 2016 Mar 8. Cancer Treat Rev. 2016. PMID: 26975021 Free article. Review.
Variants and new entities of bladder cancer.
Lopez-Beltran A, Henriques V, Montironi R, Cimadamore A, Raspollini MR, Cheng L. Lopez-Beltran A, et al. Histopathology. 2019 Jan;74(1):77-96. doi: 10.1111/his.13752. Histopathology. 2019. PMID: 30565299 Review.
Epigenetic modulations and lineage plasticity in advanced prostate cancer.
Ge R, Wang Z, Montironi R, Jiang Z, Cheng M, Santoni M, Huang K, Massari F, Lu X, Cimadamore A, Lopez-Beltran A, Cheng L. Ge R, et al. Among authors: lopez beltran a. Ann Oncol. 2020 Apr;31(4):470-479. doi: 10.1016/j.annonc.2020.02.002. Epub 2020 Feb 13. Ann Oncol. 2020. PMID: 32139297 Free article. Review.
PD-L1 assessment in urothelial carcinoma: a practical approach.
Eckstein M, Cimadamore A, Hartmann A, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R, Gevaert T. Eckstein M, et al. Among authors: lopez beltran a. Ann Transl Med. 2019 Nov;7(22):690. doi: 10.21037/atm.2019.10.24. Ann Transl Med. 2019. PMID: 31930091 Free PMC article. Review.
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer.
Lopez-Beltran A, Cimadamore A, Blanca A, Massari F, Vau N, Scarpelli M, Cheng L, Montironi R. Lopez-Beltran A, et al. Cancers (Basel). 2021 Jan 3;13(1):131. doi: 10.3390/cancers13010131. Cancers (Basel). 2021. PMID: 33401585 Free PMC article. Review.
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies.
Piva F, Santoni M, Matrana MR, Satti S, Giulietti M, Occhipinti G, Massari F, Cheng L, Lopez-Beltran A, Scarpelli M, Principato G, Cascinu S, Montironi R. Piva F, et al. Among authors: lopez beltran a. Expert Rev Mol Diagn. 2015;15(9):1201-10. doi: 10.1586/14737159.2015.1068122. Epub 2015 Jul 11. Expert Rev Mol Diagn. 2015. PMID: 26166446 Review.
Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors.
Santoni M, Heng DY, Bracarda S, Procopio G, Milella M, Porta C, Matrana MR, Cartenì G, Crabb SJ, De Giorgi U, Basso U, Masini C, Calabrò F, Vitale MG, Santini D, Massari F, Galli L, Fornarini G, Ricotta R, Buti S, Zucali P, Caffo O, Morelli F, Carrozza F, Martignetti A, Gelibter A, Iacovelli R, Mosca A, Atzori F, Vau N, Incorvaia L, Ortega C, Scarpelli M, Lopez-Beltran A, Cheng L, Paolucci V, Graham J, Pierce E, Scagliarini S, Sepe P, Verzoni E, Merler S, Rizzo M, Sorgentoni G, Conti A, Piva F, Cimadamore A, Montironi R, Battelli N. Santoni M, et al. Among authors: lopez beltran a. Cancers (Basel). 2019 Dec 30;12(1):84. doi: 10.3390/cancers12010084. Cancers (Basel). 2019. PMID: 31905816 Free PMC article.
621 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page